What is Seer, Inc. (SEER) stock price today?

Seer, Inc. (SEER) is currently trading at $2.19, up 0.92% today.

What is SEER P/E ratio?

Seer, Inc.'s P/E ratio is -1.91. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is SEER return on equity (ROE)?

Seer, Inc.'s return on equity (ROE) is -27.23%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Seer, Inc.'s market cap?

Seer, Inc. has a market capitalization of $120.41M.

NASDAQ · Biotechnology

Seer, Inc. (SEER) Stock

$2.19 +0.92% NASDAQ: SEER Healthcare

Valuation

Metric	Value
Price	$2.19
Market Cap	$120.41M
P/E Ratio	-1.91
P/B Ratio	0.57
P/S Ratio	9.23
EPS (TTM)	$-1.28
52-Week High	$2.41
52-Week Low	$1.55
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-27.23%
ROA	-26.48%
ROCE	-28.87%
Gross Margin	48.26%
Operating Margin	-4.96%
Net Margin	-490.71%
Debt/Equity	0.10
Current Ratio	12.63

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$6.0M	$15.0M	$15.0M	$14.0M	$16.0M
Operating Profit	$-72.0M	$-98.0M	$-105.0M	$-100.0M	$-78.0M
Net Profit	$-71.0M	$-93.0M	$-86.0M	$-87.0M	$-74.0M
EPS	$-1.13	$-1.42	$-1.35	$-1.39	$-1.28
Op Margin	-1121.3%	-667.6%	-691.2%	-717.7%	-483.9%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$539.0M	$488.0M	$436.0M	$367.0M	$296.0M
Total Liabilities	$36.0M	$41.0M	$39.0M	$39.0M	$37.0M
Cash	$233.0M	$53.0M	$32.0M	$41.0M	$47.0M
Borrowings	$23.0M	$30.0M	$28.0M	$26.0M	$24.0M

Latest News

Radoff-JEC Group Announces That Glass Lewis Has Joined ISS in Supporting its Case for Change at Seer, Inc. Business Wire · Jul 22, 2026 Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY GlobeNewswire · Jul 20, 2026 Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. GlobeNewswire · Jul 20, 2026 Radoff-JEC Group Announces ISS’ Support of its Case for Change at Seer, Inc. Business Wire · Jul 17, 2026 Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight GlobeNewswire · Jul 14, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-46.0M	$-61.0M	$-59.0M	$-46.0M	$-44.0M
Investing Cash Flow	$-178.0M	$-133.0M	$31.0M	$62.0M	$60.0M
Financing Cash Flow	$14.0M	$4.0M	$0	$-11.0M	$-11.0M
Net Cash Flow	$-101.0M	$-180.0M	$-21.0M	$8.0M	$7.0M
Free Cash Flow	$-53.0M	$-71.0M	$-66.0M	$-50.0M	$-46.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.16
EV / EBITDA	-1.93
FCF Yield	-34.60%
Quick Ratio	14.06
Interest Coverage	0.00
Return 1Y	1.41%
Return 3Y	-54.81%
Return 5Y	-92.19%

Ownership

Insiders Held14.46%

Institutions Held51.27%

Institutions Float Held59.94%

Institutional Holder	Shares	Report Date
Softbank Group Corporation	5,135,383	2026-03-31
Siren, L.L.C.	2,458,673	2026-03-31
Acadian Asset Management. LLC	2,074,709	2026-03-31
Vanguard Capital Management LLC	1,958,996	2026-03-31
Blackrock Inc.	1,821,604	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ANEBAnebulo Pharmaceuticals, Inc.	$0.34	+0.00%	-1.73	$13.72M	0.00%
ANTXAN2 Therapeutics, Inc.	$4.40	-5.98%	-5.24	$158.47M	0.00%
CCCCC4 Therapeutics, Inc.	$3.16	+10.88%	-2.95	$349.39M	0.00%
CGEMCullinan Therapeutics, Inc.	$15.53	+0.45%	-4.60	$954.44M	0.00%
FHTXFoghorn Therapeutics Inc.	$2.00	+0.50%	-2.11	$117.43M	0.00%

About Seer, Inc.

Seer, Inc. is led by CEO Omid C. Farokhzad, employs 134 people, headquartered in US, publicly traded since 2020.

Seer, Inc. (SEER) stock trades at $2.19 with a market capitalization of $120.41M. The stock is valued at a price-to-earnings (P/E) ratio of -1.91, price-to-book of 0.57, price-to-sales of 9.23. Over the past 52 weeks the stock has ranged between $1.55 and $2.41, and currently trades 9.1% below its 52-week high.

On profitability, Seer, Inc. generates a return on equity (ROE) of -27.23%, return on capital employed of -28.87%, an operating margin of -4.96%, a net profit margin of -490.71%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides